Tech Meridian ← ENTITY INDEX
PROMY MERIDIAN RU

COMPANY · ENTITY #9597

Moderna

Related event timeline, sources and context from the news index.

EVENT TIMELINE

2

COMPANIES · 3 SOURCES · OpenAI · TechCrunch AI · The Decoder

OpenAI acquires Orchestra Bio to bring AI to life‑sciences R&D

OpenAI is acquiring Orchestra Bio to integrate AI-powered operations into life‑sciences R&D, aiming to help biopharma teams accelerate drug development and advance new treatments. The move positions OpenAI to extend its AI capabilities into laboratory and research workflows in the life‑sciences sector.

8.0

RESEARCH · 1 SOURCE · MIT News AI

MIT uses AI to formulate mRNA lipid nanoparticles stable at room temperature

MIT researchers (Koch Institute and CSAIL) used a machine-learning algorithm to screen ~50 FDA-approved excipients and identify formulations that make FDA-like lipid nanoparticle (LNP) mRNA vaccines far more heat-resistant—remaining stable at room temperature for up to a year or at nearly 100°F (~38°C) for two months. In mice, COVID-19 vaccine formulations derived from the AI-guided optimization produced immune responses comparable to an mRNA vaccine similar to Moderna’s; the work is reported in Nature Biotechnology.

8.0